FOLH1 and neoplasm: Another clinical application referred to the investigation of [177Lu]Lu-EB-PSMA-617, which revealed increased tumor accumulation as compared with [177Lu]Lu-PSMA-617, but also higher uptake in kidneys and blood [36].